All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| PQ / Petroquest Energy, Inc.
|
|
|
|
|
|
|
|
| COLL / Collegium Pharmaceutical, Inc.
|
|
|
|
|
|
|
|
| HNSN / Hansen Medical, Inc.
|
|
|
|
|
|
|
|
| COG / Cabot Oil & Gas Corp.
|
|
|
|
|
|
|
|
| PXD / Pioneer Natural Resources Company
|
|
|
|
|
|
|
|
| MASI / Masimo Corporation
|
|
|
|
|
|
|
|
| MRK / Merck & Co., Inc.
|
|
|
|
|
|
|
|
| AEGR / Aegerion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| NXTM / NxStage Medical, Inc.
|
|
|
|
|
|
|
|
| ROKA / Roka Bioscience, Inc.
|
|
|
|
|
|
|
|
| ARAY / Accuray Incorporated
|
|
|
|
|
|
|
|
| TSRO / TESARO, Inc.
|
|
|
|
|
|
|
|
| GILD / Gilead Sciences, Inc.
|
|
|
|
|
|
|
|
| AWH / Aspira Women's Health Inc.
|
|
|
|
|
|
|
|
| / Oxford Immunotec Global PLC
|
|
|
|
|
|
|
|
| CALA / Calithera Biosciences, Inc.
|
|
|
|
|
|
|
|
| PBYI / Puma Biotechnology, Inc.
|
|
|
|
|
|
|
|
| OMED / OptMed Inc
|
|
|
|
|
|
|
|
| RPTP / Raptor Pharmaceutical Corp.
|
|
|
|
|
|
|
|
| CERS / Cerus Corporation
|
|
|
|
|
|
|
|
| MDVN / Medivation, Inc.
|
|
|
|
|
|
|
|
| CELGZ / Celgene Corporation Series A Contingent Value Rights
|
|
|
|
|
|
|
|
| TTHI / Transition Therapeutics Inc.
|
|
|
|
|
|
|
|
| AGIO / Agios Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| 98235T107 / Wright Medical Group N.V.
|
|
|
|
|
|
|
|
| NSPR / InspireMD, Inc.
|
|
|
|
|
|
|
|
| SWN / Southwestern Energy Company
|
|
|
|
|
|
|
|
| ADXS / Ayala Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CFRX / ContraFect Corp
|
|
|
|
|
|
|
|
| ECA / EnCana Corp.
|
|
|
|
|
|
|
|
| MACK / Merrimack Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| BIIB / Biogen Inc.
|
|
|
|
|
|
|
|
| CLR / Continental Resources Inc (OKLA)
|
|
|
|
|
|
|
|
| QDEL / QuidelOrtho Corporation
|
|
|
|
|
|
|
|
| SIEN / Sientra, Inc.
|
|
|
|
|
|
|
|
| CELG / Celgene Corp.
|
|
|
|
|
|
|
|
| EQT / EQT Corporation
|
|
|
|
|
|
|
|
| QTNT / Quotient Ltd
|
|
|
|
|
|
|
|
| BIOL / BIOLASE, Inc.
|
|
|
|
|
|
|
|
| PTCT / PTC Therapeutics, Inc.
|
|
|
|
|
|
|
|
| KURA / Kura Oncology, Inc.
|
|
|
|
|
|
|
|
| AXDX / Accelerate Diagnostics, Inc.
|
|
|
|
|
|
|
|
| XNCR / Xencor, Inc.
|
|
|
|
|
|
|
|
| YTEN / Yield10 Bioscience, Inc.
|
|
|
|
|
|
|
|
| CHRS / Coherus Oncology, Inc.
|
|
|
|
|
|
|
|
| CORT / Corcept Therapeutics Incorporated
|
|
|
|
|
|
|
|
| NBIX / Neurocrine Biosciences, Inc.
|
|
|
|
|
|
|
|
